The below Parliamentary question was asked by David Amess on 2016-07-06.
To ask the Minister for the Cabinet Office, if the Government will bring forward proposals to limit the duration of public inquiries.
Matthew Hancock
The running of a public inquiry is normally a matter for the independent Chair. However, good practice is that when establishing a public inquiry, Departments should seek to include in the terms of reference an estimate of the likely duration of the Inquiry.
The below Parliamentary question was asked by David Amess on 2015-10-30.
To ask the Secretary of State for Health, how much the NHS spent on treating patients with glaucoma in each of the last three years.
Alistair Burt
Cost information is shown in the following table from reference costs, which are the average unit cost to National Health Service trusts and foundation trusts of providing defined services in a given financial year. The table shows the costs of a surgical procedure covering one episode of care under one consultant in an admitted patient or outpatient setting and does not include other elements of the patient pathway such as GP consultations or outpatient appointments. It is not possible to separately identify the costs of glaucoma in non-surgical appointments.
Costs associated with glaucoma procedures, 2011/12 – 2013/14
|
Healthcare Resource Group (HRG) |
Activity |
National average unit cost £ |
Estimated total cost £ million |
|
2011/12 |
|||
|
Major Glaucoma Procedures |
2,248 |
£1,440 |
£3.2m |
|
Intermediate Glaucoma Procedures |
33,842 |
£387 |
£13.1m |
|
Minor Glaucoma Procedures |
17,194 |
£293 |
£5.0m |
|
Total |
£21.3m |
||
|
2012/13 |
|||
|
Major Glaucoma Procedures, with CC Score 1+ |
1,206 |
£1,665 |
£2.0m |
|
Major Glaucoma Procedures, with CC Score 0 |
2,622 |
£885 |
£2.3m |
|
Intermediate Glaucoma Procedures, with CC Score 1+ |
3,167 |
£1,250 |
£4.0m |
|
Intermediate Glaucoma Procedures, with CC Score 0 |
17,410 |
£451 |
£7.9m |
|
Minor Glaucoma Procedures, with CC Score 1+ |
2,014 |
£773 |
£1.6m |
|
Minor Glaucoma Procedures, with CC Score 0 |
19,243 |
£198 |
£3.8m |
|
Total |
£21.6m |
||
|
2013/14 |
|||
|
Major Glaucoma Procedures with CC Score 1+ |
1,709 |
£1,689 |
£2.9m |
|
Major Glaucoma Procedures with CC Score 0 |
3,129 |
£884 |
£2.8m |
|
Intermediate Glaucoma Procedures with CC Score 1+ |
3,384 |
£1,236 |
£4.2m |
|
Intermediate Glaucoma Procedures with CC Score 0 |
9,297 |
£772 |
£7.2m |
|
Minor Glaucoma Procedures with CC Score 1+ |
2,142 |
£680 |
£1.5m |
|
Minor Glaucoma Procedures with CC Score 0 |
24,688 |
£181 |
£4.5m |
|
Total |
£23.1m |
Source: Reference costs, Department of Health
Notes:
The below Parliamentary question was asked by David Amess on 2015-11-23.
To ask the Secretary of State for Education, pursuant to the Answer of 27 October 2015 to Question 13645, what the names of each head teacher and the school to which they belong are with whom her Department is currently working to improve the provision of PSHE in schools; and if she will make a statement.
Edward Timpson
The Department for Education regularly speaks to a wide range of head teachers, academy chief executives, teachers and subject associations. We invited a group of headteachers and PSHE practitioners to work with us on improving the quality of PSHE.
These individuals were selected because of the high quality provision in their schools. The list of contributors will be known when the report is published.
The below Parliamentary question was asked by David Amess on 2015-12-15.
To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment her Department has made of the implications for its policies of the report from the All-Party Parliamentary Group for Animal Welfare, The Urgent Need for an Effective, Enforceable and Enforced Equine Identification System, published in February 2014; and if she will bring forward proposals for such a system to be in place before the end of the current Parliament.
George Eustice
Defra accepts that the current EU system for equine identification does not work well and has pushed for a strengthened regime which is fit for purpose throughout Europe. Defra is now working with the other Governments of the United Kingdom, enforcement authorities and the equine sector to implement a new EU regulation which will help to ensure the regime operates effectively and efficiently in the future.
The below Parliamentary question was asked by David Amess on 2016-01-22.
To ask the Secretary of State for International Development, what outcomes her Department is working for at the Supporting Syria and the Region Conference in February 2016.
Mr Desmond Swayne
Through the “Supporting Syria and the Region (London 2016)” Conference we aim to raise significant new funding to meet the immediate and longer-term needs of all those affected by the crisis within Syria, and to support neighbouring countries who have shown enormous generosity in hosting refugees.
The Conference will address the longer-term needs of those affected by the crisis through supporting the creation of jobs and providing education in the region, offering those that have been forced to flee their homes greater hope for the future. Specifically, we aim to ensure access to education for all refugee and host community children by the end of the 2016-17 school year.
The Conference will also maintain pressure on all parties to the conflict to stop the obstruction of humanitarian relief and abuse of civilians that perpetuate the crisis and respect International Humanitarian Law. We aim to agree action to give people inside Syria safer healthcare, safer education, and support for the most vulnerable, especially girls and women. Looking ahead, it will need to ensure the international community is well prepared to support a coordinated stabilisation effort.
The below Parliamentary question was asked by David Amess on 2016-03-01.
To ask the Secretary of State for Health, what estimate his Department has made of the number of patients who will be able to access treatments for colorectal cancer on the NHS from April 2016.
George Freeman
NHS England has advised that all patients diagnosed with colorectal cancer will continue to be able to access treatment for their disease. It is not possible to estimate the numbers of patients who will be able to access both current and future specific treatments for colorectal cancers as there is a wide range of treatments available and these are ever changing.
The below Parliamentary question was asked by David Amess on 2016-03-14.
To ask the Secretary of State for Environment, Food and Rural Affairs, what steps the Government is taking to put in place a blue belt to protect marine habitats and species.
George Eustice
Since 2013, we have designated 50 Marine Conservation Zones (MCZs), which protect a range of habitats and species. A third tranche of MCZs will be designated in 2018.
We are currently undertaking work to identify a complete network of Special Protection Areas for seabirds, and consulting on five Special Areas of Conservation for harbour porpoise.
Over 17% of UK waters and almost a third of English inshore waters are now within Marine Protected Areas.
The below Parliamentary question was asked by David Amess on 2016-07-11.
To ask the Secretary of State for Education, if her Department will take steps to ensure that new investment in the Primary PE and Sport Premium directly benefits (a) the least active children and (b) children from poorer socio-economic backgrounds.
Edward Timpson
We want all pupils to be healthy and active. We have ring-fenced over £450 million to improve PE and sport in primary schools (2013/14 – 2015/16), and committed to doubling the primary PE and sport premium to £320 million a year from September 2017 using revenue from the soft drinks industry levy. Schools have the freedom to decide how to use the funding based on the needs of their pupils, and can choose to target funding on the least active and children from poorer socio-economic backgrounds. Schools are accountable for their spending through Ofsted inspections and are required to report plans and impact online.
We have evaluated the impact and schools’ use of the premium through the independent research company, NatCen. Evidence indicates the funding is having a positive impact and schools reported almost universally that the PE and sport premium had had a positive impact on physical fitness (99%), healthy lifestyles (99%), skills (98%) and behaviour of pupils (96%).[1].
We are currently exploring options for future evaluation once the premium is doubled. Further details will be announced in due course.
[1] Evidence from the 2015 report, based on findings of a two year study between 2013 – 2015: https://www.gov.uk/government/publications/pe-and-sport-premium-an-investigation-in-primary-schools
“
The below Parliamentary question was asked by David Amess on 2015-10-30.
To ask the Secretary of State for Health, how much the NHS spent on treating patients with diabetic retinopathy in each of the last three years.
Jane Ellison
We do not hold this information in the format requested.
The below Parliamentary question was asked by David Amess on 2015-11-25.
To ask the Secretary of State for Health, what steps he is taking to encourage the provision of take-home naloxone for at risk prisoners by health and justice lead area teams; and if he will make a statement.
Jane Ellison
The substance misuse element of the harm reduction strategy will align with national clinical guidance with regard to how naloxone and other medicines in the care pathway are considered for use, although specific medicines are unlikely to be named in the strategy.
The commissioning of substance misuse treatment for prisoners is the responsibility of health and justice commissioning teams in ten of NHS England’s area teams, supported by a central health and justice team. The Government expects commissioners and providers of substance misuse services in prisons and in the community to work together closely in respect to prisoners being released from custody to ensure seamless transfers of care.
Public Health England, the Department and the Medicines and Healthcare products Regulatory Agency have jointly published a factsheet[1] to explain October’s regulatory change with regard to naloxone and how the wider availability of naloxone affects relevant services. NHS England Area Teams will encourage providers to take account of this guidance.
[1] https://www.gov.uk/government/publications/widening-the-availability-of-naloxone/widening-the-availability-of-naloxone
“